Stay updated on Clinical Trial Assessing IBI310 Similarity to Ipilimumab
Sign up to get notified when there's something new on the Clinical Trial Assessing IBI310 Similarity to Ipilimumab page.

Latest updates to the Clinical Trial Assessing IBI310 Similarity to Ipilimumab page
- Check2 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check45 days agoChange DetectedThe page has undergone a version update from v2.14.4 to v2.15.0, and the status of a previously listed item has changed from 'Active, not recruiting' to 'Completed'.SummaryDifference4%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check96 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check110 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
Stay in the know with updates to Clinical Trial Assessing IBI310 Similarity to Ipilimumab
Enter your email address, and we'll notify you when there's something new on the Clinical Trial Assessing IBI310 Similarity to Ipilimumab page.